CDK4 and neoplasm: It has been demonstrated that pharmacological inhibitors of CDK4/6, could directly arresting tumor cells in the G1 phase of the cell cycle.[22] Additionally, CDK4/6 inhibitors (CDK4/6i) could modulate anti‐tumor immunity in several ways.